The RNA alphavirus Semliki Forest (SFV) triggers apoptosis in various mammalian cells, but it has remained controversial at what infection stage and by which signalling pathways host cells are killed. Both RNA synthesis-dependent and -independent initiation processes and mitochondrial as well as death receptor signalling pathways have been implicated. Here, we show that SFV-induced apoptosis is initiated at the level of RNA replication or thereafter. Moreover, by expressing antiapoptotic genes from recombinant SFV (replicons) and by using neutralizing reagents and gene-knockout cells, we provide clear evidence that SFV does not require CD95L-, TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-or tumor necrosis factormediated signalling but mitochondrial Bak to trigger cytochrome c release, the fall in the mitochondrial membrane potential, apoptotic protease-activating factor-1/caspase-9 apoptosome formation and caspase-3/-7 activation. Of seven BH3-only proteins tested, only Bid contributed to effective SFV-induced apoptosis. However, caspase-8 activation and Bid cleavage occurred downstream of Bax/Bak, indicating that truncated Bid formation serves to amplify rather than trigger SFV-induced apoptosis. Our data show that SFV sequentially activates a mitochondrial, Bak-mediated, caspase-8-dependent and Bid-mediated death signalling pathway that can be accurately dissected with gene-knockout cells and SFV replicons carrying antiapoptotic genes. 1 Alphaviruses can be a serious health threat for humans because some strains cause fatal encephalitis or epidemic polyarthritis. For laboratory purposes, two strains, SFV and Sindbis virus (SIN), are used because they have a broad host range, replicate to high titers in many cells and are usually considered avirulent for humans.
1
Alphaviruses are known to trigger hallmarks of apoptosis in various cultured cells [3] [4] [5] as well as in vivo. 5, 6 This cytotoxicity has recently been exploited to kill cancer cells. 7 On the other hand, cytotoxicity is a problem for the use of viral vectors for gene therapies. 5, 8 It is therefore necessary to understand the molecular events responsible for the demise of alphavirusinfected cells. Both death receptor and mitochondrial apoptosis signalling pathways were shown to be implicated in apoptosis induced by viruses. In the death receptor pathway, stimulation of Fas/CD95, tumor necrosis factor (TNF)-R1, or tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-R1 or TRAIL-R2 leads to the formation of the death-inducing signalling complex (DISC), consisting of the adapter Fas-associated death domain and the initiator caspase-8, which directly cleaves and activates effector caspase-3 and caspase-7. 9 The mitochondrial pathway is initiated in response to diverse apoptotic stimuli that activate so-called Bcl-2 homology domain 3 (BH3)-only proteins by transcriptional or post-transcriptional means. 10 These proteins trigger the mitochondrial membrane pore-forming activity of the proapoptotic Bcl-2 family members Bax and Bak by yet unknown mechanisms, [11] [12] [13] leading to the release of cytochrome c and other apoptogenic factors. Cytochrome c recruits apoptotic protease-activating factor-1 (Apaf-1) and caspase-9 into a high molecular mass apoptosome complex, which in turn cleaves and activates caspase-3 and caspase-7.
14 This death signalling pathway can be inhibited by overexpression of the antiapoptotic Bcl-2 family members Bcl-2, Bcl-x L or Mcl-1. 11 The death receptor and mitochondrial pathways can cross talk through the BH3-only protein Bid, which, under conditions of low DISC formation, is cleaved by caspase-8 to a truncated form (tBid) that is targeted to mitochondria to activate Bak and Bax. 15 For DNA viruses, virally encoded survival factors of the Bcl-2 family or proteins interfering with death receptor signalling have helped to dissect the death signalling pathways in host cells. 16, 17 By contrast, RNA viruses usually do not encode survival factors in their genome, and hence uncovering the relevant death signalling components has been more difficult. [18] [19] [20] [21] [22] [23] [24] Here, we show that SFV requires an intact RNA genome and a Bak/ mitochondria-mediated signalling pathway for apoptosis induction.
Results
SFV requires an intact RNA genome for caspasedependent and caspase-independent apoptosis. It has been controversial whether SFV or SIN kills host cells via receptor binding/endocytosis or RNA replication. [25] [26] [27] By infecting 3T9 mouse embryonic fibroblasts (MEFs) with ultraviolet (UV)-inactivated SFV and monitoring virus uptake, RNA replication and apoptosis induction, we clearly show that SFV requires an intact RNA genome to induce classical features of apoptosis (Supplementary Material and Supplementary Figure 1 ). Effective apoptosis is mediated via the activation of caspases. As shown in Figure 1a and b, SFV induced caspase-3/-7 activity and pro-caspase-3 cleavage to the active p17 fragment at 0-36 h post-infection (h.p.i.). To test if caspase-3 and/or caspase-7 were required for SFV-induced apoptosis, we infected simian virus 40 (SV40)-transformed caspase-3À/À, caspase-7À/À or caspase-3/-7 double-knockout (DKO) MEFs with SFV for 0-36 h and analyzed the cells for PS exposure and membrane permeability. Figure 1c shows that all three knockout cell lines were similarly protected from green fluorescent protein (GFP)-annexin-V/propidium iodide (PI) staining. However, PS exposure and increased membrane permeability were evident with time indicating the coexistence of a caspaseindependent death signalling pathway. To bolster our findings, we treated SV40 MEFs with 25 mM of the broadrange caspase inhibitor Q-Val-Asp O-Ph, non-O-methylated (Q-VD-OPH) during SFV infection. GFP-annexin-V/PI staining of these cells revealed a marked delay but not blockage of SFV-induced apoptosis in the presence of Q-VD-OPH (Figure 1c) . Moreover, nuclear fragmentation, a caspase-3/-7-mediated response, was greatly diminished in Q-VD-OPH-treated cells (Figure 1d ). Thus, caspase-3 and caspase-7 are dominant and redundant mediators of SFVinduced apoptosis, but the virus also triggers a caspaseindependent death program.
SFV uses the mitochondrial/apoptosomal pathway for apoptosis induction. To delineate the signalling components of SFV-induced apoptosis, we first investigated the mitochondrial pathway. For that purpose, we investigated cytochrome c release of SFV-infected MEFs by immunofluorescence and immunoblot analyses and compared this release to the proteolytic processing and activation of caspase-3. As shown in Figure 2a , after 10 h.p.i., cytochrome c changed its localization from elongated mitochondrial structures to the cytosol. Each cell showing diffusely stained cytochrome c also stained positive for active caspase-3, indicating that cytochrome c release occurred before or concomitant with caspase-3 activation. Western blot analysis confirmed that cytochrome c appeared in cytosolic fractions at 410 h.p.i. and that this correlated with caspase-3 processing to the active 17-kDa fragment ( Figure 2b ). Next, we studied the formation of the Apaf-1/ caspase-9 apoptosome, a known downstream effector of cytochrome c. Using Superose 6 gel filtration chromatography of mock-and SFV-infected MEF cytosols, we observed the formation of high molecular mass Apaf-1/ caspase-9 complexes (700 kDa) by 14 h.p.i. (Figure 2c ). Moreover, caspase-9 appeared to be activated, as it was processed from its p46 proform to the active p37/p35 forms at 14-24 h.p.i. (Figure 2d ). In agreement with these findings, 3T9 MEFs deficient of caspase-9 and Apaf-1 showed markedly decreased apoptosis after 24-36 h.p.i. as quantified by GFP-annexin-V/PI staining (Figure 2e ). However, apoptosis was not entirely blocked, as up to 40% (24 h ) and 55% (36 h) of the SFV-infected KO cells continued to die (Figure 2e ).
SFV predominantly uses Bak and not Bax for cytochrome c release and effective apoptosis induction. Mitochondrial membrane perforation depends on the action of Bax and Bak, as in their absence cytochrome c release and apoptosis are blocked. 28 To determine if Bax and Bak contributed equally to cell killing in response to SFV, we measured cytochrome c release, the fall in the mitochondrial membrane potential (DC m ), caspase-3 activation, and the extent of cell death (methyl thiazolyl tetrazolium (MTT) assay) and apoptosis (GFP-annexin-V/PI staining) in BaxÀ/À, BakÀ/À and Bax/Bak DKO 3T9 cells at 0-36 h.p.i. For this analysis, cytochrome c release was measured by a quantitative fluorescence-activated cell sorter (FACS) analysis on digitonin-permeabilized fixed cells. Strikingly, BaxÀ/À 3T9 MEFs were more susceptible to SFV-induced cell death/apoptosis than wild-type (wt) cells (Figure 3a and b) and hence displayed a greater cytochrome c release (Figure 3c ), DC m diminution ( Figure 3d ) and caspase-3 processing/activation (Figure 3e and f) at all times after SFV infection. By contrast, as expected, Bax/Bak DKO 3T9s were protected from cell death induced by SFV ( Figure  3a and b) . At 24 h.p.i., DC m was still maintained, and cytochrome c release and caspase-3 activation were hardly detected (Figure 3c-f) . However, as with caspase-3À/À, caspase-9À/À and Apaf-1À/À cells, cell death continued at later time points (Figure 3a and b) , indicating the coexistence of a Bax/Bak-independent death signalling pathway. The marked difference in apoptosis susceptibility of BaxÀ/À and Bax/Bak DKO cells suggested a crucial role of Bak in SFVinduced apoptosis. Indeed, BakÀ/À 3T9 cells were almost as resistant to SFV-induced cell death and apoptosis as Bax/ Bak DKO (Figure 3a and b) . In addition, BakÀ/À cells exhibited a markedly delayed cytochrome c release (Figure 3c ), fall in DC m (Figure 3d ) and caspase-3 processing (Figure 3e and f) . Consistently, we detected a significant Bak activation by FACS analysis of its N-terminal conformational change in wt (21-39%) and BaxÀ/À (26%) 3T9s at 14-24 h.p.i. (Figure 3g ). Such a conformational change was seen only slightly for Bax, even in BakÀ/À cells (9%) (Figure 3g ). Importantly, cell death protection of ). Although this protection was only 20-25%, it was significant, occurred in two independent cell lines isolated from two different mouse genotypes (BidÀ/À and Bid/Bim DKO) and was also detected in the MTT viability assay (Figure 4c ). These data demonstrate that SFV does not depend on the single BH3-only proteins Bim, Bmf, Noxa, Puma, Bad or Bik for apoptosis induction but relies partially on Bid.
Caspase-8 and tBid are downstream amplifiers of mitochondrial signaling. SIN-induced apoptosis was shown to be inhibited by the caspase-8 inhibitors FLIP (Fas-associating protein with death domain-like interleukin-1 b-converting enzyme inhibitory protein) 23 and crmA (cytokine response modifier A). 24 This suggested the involvement of the extrinsic death receptor pathway in alphavirus-induced apoptosis and would explain the partial dependence on the major caspase-8 substrate Bid. By using neutralizing antibodies or F c constructs to Fas, TRAIL-R2 and TNF-R1 as well as to their ligands, we found that SFV did not require death receptors or ligands for apoptosis signalling (Supplementary Material and Supplementary Figure 2) . Western blot analysis of caspase-8 and Bid, however, revealed that both proteins were cleaved to their active forms in response to SFV infection. Strikingly, both cleavages were significantly delayed and even blocked in BakÀ/À and Bax/Bak DKO cells, respectively ( Figure 5 ). On the other hand, as seen for cytochrome c release, DC m diminution, caspase-3 activation and extent of cell death (Figure 3 ), the processing of caspase-8 and Bid was even faster in BaxÀ/À than wt cells ( Figure 5 ). These data strongly indicate that caspase-8 activation and tBid formation were Bak dependent and thus occurred downstream of mitochondria.
Replicon-based SFV carrying antiapoptotic genes confirms the role of the mitochondrial pathway in SFV-induced apoptosis. To confirm the implication of the mitochondrial signalling pathway in SFV-induced apoptosis, we generated replicon-based recombinant SFV (rSFV) where the structural genes were replaced by the reporter gene GFP (pSFV2subGFP wt) and an antiapoptotic gene of interest under two 26S subgenomic promoters in tandem (26S#1 and 26S#2) (Figure 6a ). The rationale of this approach was that after transduction of such viruses, the expression of the antiapoptotic transgene would interfere with a particular apoptosis signalling pathway, provided that its expression was sufficiently high and faster than apoptosis execution by the virus. Moreover, by the simultaneous expression of GFP and the antiapoptotic gene, it was possible to determine transfection efficiency and transgene expression and to monitor the apoptotic fate (PI staining) of the GFP-positive cells by FACS analysis without selecting cell clones. We generated recombinant viruses carrying Bcl-2, the caspase-3/-9 inhibitor X-linked inhibitor of apoptosis protein (XIAP), the caspase-8 inhibitor crmA or dominant-negative (DN) forms of caspase-8 or caspase-9. Infection of 3T9 MEFs with these viruses resulted in the coexpression of GFP and the respective antiapoptotic transgene (Figure 6b ). To quantify cell death by rSFV, we performed an FACS analysis where the expression of the transgenes was measured by GFP fluorescence and cell death by PI staining (secondary necrotic cells, see above). As shown in Figure 6c , mock-infected 3T9 cells displayed no GFP (no transgene expression) and only little PI staining. By contrast, cells infected with the recombinant wt rSFV-GFP showed a double-positive GFP/PI staining after 24 h indicative of cell death of GFP-positive cells (Figure 6c) . The cell death kinetics between infections with the native SFV and recombinant wt SFV were strikingly similar over a range of 0-72 h.p.i. (Figure 6d) . Moreover, as for the native SFV, cell death induced by rSFV was both caspasedependent and caspase-independent, as the addition of Q-VD-OPH blocked only approximately 50% of GFP/PI positivity (Figure 6d ). This indicates that the structural genes, which are missing in rSFV, are not needed for cell death induced by SFV. As expected from our data above, 3T9 MEFs infected with rSFV carrying Bcl-2, XIAP or caspase-9 DN showed only a few PI-positive cells and By contrast, cells infected with SFV containing crmA or caspase-8 DN were more readily killed but not as much as with recombinant wt rSFV-GFP (Figure 6e ). These data show that rSFV expressing antiapoptotic genes can be used to dissect apoptosis signalling pathways and confirm that the major pathway used by SFV passes through mitochondria and the apoptosome with a possible downstream amplification via caspase-8.
Discussion
We present three novel findings on the mechanisms of SFVinduced apoptosis. Firstly, apoptosis of the host is initiated at the level of viral RNA replication or thereafter. Secondly, apoptotic signalling involves the mitochondrial pathway with a preferential activation of Bak over Bax. Thirdly, effective apoptosis seems to depend, at least in part, on an amplification loop implying a caspase-8-mediated cleavage of Bid downstream of mitochondria. In addition, we show for the first time that recombinant alphaviruses (replicons) expressing various death inhibitors can be used to dissect virus-induced death signalling pathways. The successful blockage of apoptosis signalling by replicons encoding antiapoptotic proteins confirms that SFV does not initiate apoptosis before RNA replication/transcription. Moreover, as shown by plaque assays (Table 1) , virus formation was independent of apoptosis sensitivity. Our findings, however, contradict a previous report stating that SIN-induced apoptosis was initiated at the level of viral entry. 25 A possible explanation for this discrepancy may be the 20-to 50-fold higher infection dose (200-500 multiplicity of infection (m.o.i.)) used in their UV-inactivation experiment. We found that if MEFs were infected with 200 instead of 10 m.o.i. of UV-inactivated SFV, the cells were still killed and produced lower titers of viruses, indicating that with higher m.o.i. the RNA genome may have been incompletely inactivated by UV (Supplementary Figure 1F and Table 1) .
Another controversy has been the nature of the apoptosis signalling pathway activated by alphaviruses. For both SFV and SIN, it was shown that overexpression of Bcl-2, Bcl-x L or their binding partner Beclin-1 blocked apoptosis. 3, 4, 6, 19, 20 Moreover, Moriishi et al. 21 reported the implication of the BH3-only protein Bad in SIN-induced apoptosis. Although these data suggested the importance of the mitochondrial pathway in alphavirus-induced apoptosis, no proof was presented using discrete knockout or knockdown expression systems. Here, we show that SFV-induced apoptosis is strongly delayed in BakÀ/À, Bax/Bak DKO, caspase-9, Apaf-1, and caspase-3 and caspase-3/-7 DKO cells. However, we could not confirm that Bad is per se an important upstream sensor/activator of the mitochondrial pathway. BadÀ/À, Bad/ Bim DKO and most other single BH3-only knockout MEFs were as sensitive to SFV-induced apoptosis as wt counterparts. Thus, SFV-induced apoptosis either does not require any BH3-only protein or is sensed by a specific combination of these proteins.
Previous reports suggested the implication of death receptor signalling in SFV-or SIN-induced apoptosis, as the caspase-8 inhibitors vFLIP and crmA could delay or prevent the death process. 23, 24 However, as the caspase-8/tBid pathway can also be activated downstream of mitochondria, presumably via caspase-6-and/or caspase-3-mediated processing of caspase-8 and/or Bid, 29 it has remained unclear if the reported apoptosis-inhibitory effects of crmA and vFLIP were due to death receptor signalling or due to the downstream mitochondrial pathway. Here, we present strong evidence for the latter, as SFV-induced caspase-8 and Bid processing was inhibited in BakÀ/À and Bax/Bak DKO MEFs. As previously suggested, 29, 30 this downstream pathway may be necessary to further activate Bak (and Bax) by tBid, ensuring effective release of apoptogenic factors from mitochondria and the execution of both caspase-dependent and caspase-independent forms of cell death. For SFVinduced apoptosis, this indeed seems to be important as both BidÀ/À and Bid/Bim DKO MEFs died in a significantly delayed manner.
Although it is generally accepted that both Bax and Bak are functionally redundant, it has been debated if their mode of activation is the same. In healthy cells/tissues, Bax is a cytoplasmic protein, 31 whereas Bak is bound to mitochondria where it is inhibited by its interaction with voltage-dependent anion channel-2 32 or with the survival factors Bcl-2, Bcl-x L and Mcl-1. 11, 12 In response to apoptotic stimuli, Bax has to translocate to mitochondria before it can oligomerize and form pores. 31 By contrast, activation of Bak appears to be much simpler, because it may just have to be released from Bcl-2-like survival factors by the competitive binding of BH3-only proteins. 11, 12 This is probably what happens in response to SFV infection. The SFV system is therefore ideal to further elucidate the exact molecular mechanism of Bak activation. Other published examples of preferred Bak over Bax activation include apoptosis induction by the fungal toxin gliotoxin 33 or the Bcl-2 family member Bcl-x S . 34 Can we then exclude the contribution of Bax to SFV-induced apoptosis? Although slightly detectable in wt cells, the N-terminal opening of Bax does not occur in BakÀ/À cells, which continued to die at later time points. Moreover, perplexingly, BaxÀ/À MEFs are more sensitive to cytochrome c release, DC m diminution, caspase-3 activation, Bid cleavage and apoptosis than wt cells. These data are consistent with the findings by Lewis et al. 35 that BaxÀ/À mice are more susceptible to SIN-induced neuronal disease and mortality than normal mice. The molecular basis of this rather death-protective action of Bax is unknown.
If the Bak-mediated mitochondrial pathway is so essential, why do Apaf-1À/À, caspase-9À/À, caspase-3/-7 DKO and even Bax/Bak DKO cells continue to die in response to SFV infection (Figures 1c, 2e, 3a and b) ? It is known that mitochondrial membrane perforation also induces caspaseindependent death signalling that cannot be blocked by inhibiting the apoptosome or caspase-3/-7. This corroborates the finding that Bax/Bak DKO MEFs are more protected against SFV-induced apoptosis than Apaf-1À/À or caspase-9À/À cells (compare Figures 3a and 2e) . Indeed, we observed a maximally 50% reduction of cell death induced by both native and rSFV when the caspase inhibitor Q-VD-OPH was included. In addition, we found that even Bax/Bak DKO cells still exhibited caspase-3 processing and residual caspase-3 activity beyond 24 h.p.i. (Figure 3e and f) . This result may explain why in some cells overexpression of Bcl-2 cannot protect against SFV-induced apoptosis because it is inactivated by caspase-3-mediated cleavage of its N terminus (NT). 22 How in this case caspase-3 is activated remains to be determined.
The second important question is how SFV launches death signalling within its host. As shown here, initiation occurs during or after RNA replication. The involvement of the capsid serine protease in caspase processing/activation can be excluded because rSFV lacking its expression kills as efficiently as native viruses. Similarly, although Glasgow et al. 36 reported that a single mutation in E2 decreased the cytotoxicity and virulence of SFV in mice, we do not think that envelope proteins contribute greatly to the initiation of SFV-induced apoptosis. By contrast, the involvement of the non-structural cysteine protease nsP2 is more difficult to disentangle. Point mutations in nsP2 attenuate or suppress both the cytotoxicity and the shut-off of host protein synthesis, and therefore such mutations may be the basis for the development of new, less cytotoxic and non-cytotoxic SFV and SIN vectors. 27, 37 However, as nsP2 is also essential for RNA replication, it cannot be discriminated if its cytotoxic action is due to the lack of RNA production, the inhibition of protein synthesis or the processing/activation of initiator or effector caspases. Here we obtained evidence that inhibition of protein synthesis is not sufficient to trigger the apoptotic program. Firstly, apoptosis induced by the protein synthesis inhibitor cycloheximide is much slower and less efficient than SFV-induced apoptosis (Supplementary Material and Supplementary Figure 3A) . Secondly, SFV-induced apoptosis does not lead to a major degradation of the labile survival factor Mcl-1 (Supplementary Figure 3B) , a process recently shown to be crucial for apoptosis due to protein translation inhibition. 38 Thirdly, double-stranded RNA (dsRNA)-activated protein kinase (PKR), a prominent mediator of protein synthesis shut-off in response to virus infection and a mediator of apoptosis in other cellular systems, 26 does not seem to be involved in SFV-induced apoptosis, as PKRÀ/À MEFs are as sensitive as wt cells (unpublished data). Despite this, dsRNA, which forms as an intermediate during SFV RNA replication, remains an attractive sensing component for host cell apoptosis. It will be interesting to know if the two recently identified dsRNA signalling pathways, the retinoic acid inducible gene-I and the melanoma differentiation-associated gene-5 systems, play a crucial role in this respect. 39 Materials and Methods Antibodies and reagents. The following antibodies were used: rabbit polyclonal antibodies recognizing the conformation-specific N terminus of Bax and Bak (Bax NT, Bak NT) from Upstate Biotechnology; mouse monoclonal anti-mouse Bcl-2 (clone 10C4) from Zytomed; mouse monoclonal anti-cytochrome c antibodies detecting the native (clone 6H2.B4, for immunofluorescence) or denatured (7H8.2C12, for western blotting) form from BD Pharmingen; rabbit polyclonal anti-caspase-3 antibodies, recognizing the inactive 32 kDa proform (no. 9662) and the active 17 kDa form (no. 9661) and mouse monoclonal anti-caspase-9 antibodies from Cell Signaling; mouse monoclonal anti-caspase-8 and anti-lysosomeassociated membrane protein-1 (anti-LAMP-1) antibodies from Alexis Biochemicals (San Diego, CA, USA); mouse monoclonal anti-actin (clone C4) antibody from MP Biomedicals; anti-FLAG (M2) antibodies from Sigma (USA); horseradish peroxidase-conjugated anti-rabbit or anti-mouse secondary antibodies from Jackson Immuno Research Laboratories (USA); Alexa Fluor 488-conjugated anti-mouse and Alexa Fluor 488 and Alexa Fluor 546-conjugated anti-rabbit secondary antibodies as well as mouse monoclonal anti-ATP synthase (7H10) antibody from Molecular Probes (USA). Rat monoclonal antibodies against Apaf-1 and against full-length Bid and tBid were a kind gift of DCS Huang, WEHI (Melbourne, VIC, Australia). Rabbit polyclonal antibody against the SFV capsid protein (SFV-C) was generously provided by J Pavlovic, University of Zürich, Switzerland.
The caspase inhibitor Q-VD-OPH was from MP Biomedicals, the fluorogenic caspase-3 substrate DEVD-AMC (acetyl-Asp(OMe)-Glu(OMe)-Val-Asp(OMe)-7-amino-4-methylcoumarin) from Alexis Biochemicals and the DNA-dye PI from Sigma. His-GFP-annexin-V used for quantification of apoptosis was produced according to Egger et al. 40 Recombinant tBid was a generous gift from J-C Martinou, University of Geneva, Switzerland. SFV production and titration. The SFV was produced by infecting the adherent mosquito cell line A. albopictus with an m.o.i. of 20 in L15 medium supplemented with 10% FCS and 4% Difco Bacto phosphate tryptose broth. After culturing at 281C for 24 h, the supernatant was harvested and centrifuged at 3000 Â g for 10 min to remove cell debris. The supernatant was aliquotized and stored at À801C. Virus yield was determined in culture supernatants collected from the various MEF cell lines infected with an m.o.i. of 10 by the so-called 'plaque assay.' Briefly, monolayers of Vero cells with 490% confluency were infected with 10-fold serial dilutions of virus in high-glucose DMEM supplemented with 2% FCS and 20 mM HEPES at 371C for 90 min. The inoculum was removed and replaced with an overlay of 0.4% noble agar (Difco, BD Diagnostics). Forty-eight hours later, the agar was removed, the monolayer was stained with 1% crystal violet and the plaques were counted.
Generation of recombinant viruses (replicon system). For safety reasons, the SFV expression system is based on two plasmid vectors (Figure 6a ). (i) The expression vector, the so-called replicon (pSFV2subGFP), consists of the coding region of nsPs, which are responsible for viral RNA replication, and the two subgenomic 26S promoters used for the expression of any desired foreign gene in conjunction with GFP (see above). (ii) The helper vector harbors the SFV structural genes. pSFV-Helper2 is the second generation of the SFV helper vector and it offers the additional safety feature of producing conditionally infectious particles. Mutations in the p62 precursor for the viral E2 and E3 spike proteins encoded by pHelper2 render the packaged SFV replicons cleavage-deficient and thus noninfectious. To infect cells, the p62 in the surface of these package replicons must be activated with a-chymotrypsin. Furthermore, only the replicon RNA is packaged into rSFV particles because it contains a packaging signal required for encapsidation into the nucleocapsid, whereas the helper RNA does not (Figure 6a ). This feature renders the generated virions suicidal, because, although they can replicate in their host cells, no progeny is generated, as the genetic material for production of the structural proteins is missing.
A 3 mg portion of pSFV2subGFP and of pSFV-Helper2 were linearized with NruI and SpeI, purified and added to a 50-ml in vitro transcription mix (Promega) containing 1 Â transcription buffer, 1 mM m7G(5 0 )ppp(5 0 )G (cap analogue), 5 mM dithiothreitol (DTT), 4 mM rNTP mix, 100 U RNase inhibitor and 50 U SP6 RNA polymerase. After incubation at 371C for 90 min, production of RNA was checked on 0.8% agarose gel. A 2 mg portion of recombinant vector RNA and 2 mg of helper RNA were electroporated into 5 Â 10 6 BHK-21 cells by using Bio-Rad gene pulser-X (setting 1 pulse at 50 mF, 700 V). After culturing the electroporated cells in DMEM þ 10% FCS for 48 h, the viral supernatant was harvested and filtered through 0.22 mm filter. Viral infection. MEFs were grown to 80% confluency and infected with native SFV at an m.o.i. of 10 (in one case 200) in high-glucose DMEM supplemented with 0.5% FCS while shaking. After 1 h at 371C, viral infection was stopped with 10% FCS. At specified time points after infection, the supernatant was collected and virus yields were determined by plaque assay, as described above, or cells were harvested and used for FACS or western blot analysis.
For infections with recombinant pSFV2subGFP viruses, the viral stocks were first activated by incubating with 20 mg/ml a-chymotrypsin (Sigma) for 30 min at RT. The reaction was stopped with 10 mg/ml aprotinin for another 30 min at RT. After activation, the supernatant was layered on top of a 20% sucrose solution and ultracentrifuged at 160 000 Â g for 90 min at 41C. The invisible virus pellet was resuspended in DMEM þ 0.5% FCS and used to infect MEFs as described above for the native virus.
Immunofluorescence. MEFs were grown on glass coverslips overnight and then infected with SFV. At various time points post-infection, the cells were fixed in 4% paraformaldehyde and permeabilized in 0.1% Triton X-100, as described by Egger et al. 40 The cells were then incubated with mouse monoclonal anticytochrome c (10 mg/ml; clone 6H2.B4) and polyclonal anti-caspase-3 (1 : 100; no. 9661) antibodies for 90 min followed by Alexa Fluor 488-coupled goat anti-mouse and Alexa Fluor 546-coupled anti-rabbit secondary antibodies (10 mg/ml) for 90 min. For colocalization of the SFV capsid protein with endosomal/lysosomal compartments, the cells were cotreated with polyclonal rabbit anti-SFV capsid antibody (1 : 200) and mouse monoclonal anti-LAMP-1 (1 : 1000) followed by incubation with rabbit and mouse Alexa Fluor secondary antibodies. Nuclei were stained with Hoechst 33334 (2 mg/ml; Molecular Probes) for 5 min. After treatment with the anti-fading agent Slow Fade (Molecular Probes) for 5 min, the samples were directly viewed under a confocal Zeiss LSM 510 Meta microscope equipped with the software Zeiss LSM Examiner Version 4.2.0.121.
Protein extraction and western blot analysis. For total extracts, 2 Â 10 6 MEFs were lysed in H8 buffer (20 mM Tris-HCl pH 7.5, 6 mM b-mercaptoethanol, 2 mM EDTA, 2 mM EGTA, 1% SDS) preheated to 951C. Preparation of cytosolic fractions for caspase assays was performed in homogenization buffer (2 mM MgCl 2 , 25 mM HEPES KOH, pH 7.4, 2 mM EGTA, 100 mM phenylmethylsulfonyl fluoride (PMSF), 10 mg/ml pepstatin, 10 mg/ml leupeptin, 5 mg/ml cytochalasin B, 10 mg/ml aprotinin, 10 mM DTT) by five freeze-thawing cycles and centrifugation at 100 000 Â g at 41C for 1 h. Cytosolic and mitochondrial fractions for western blotting were obtained by lysing cells with a Biospec homogenizator in ice-cold MSH buffer (210 mM mannitol, 70 mM sucrose, 20 mM HEPES, 1 mM EDTA, 100 mM PMSF, 10 mg/ml pepstatin, 10 mg/ml leupeptin, 5 mg/ml cytochalasin B, 10 mg/ml aprotinin). The cell suspension was centrifuged at 400 Â g at 41C for 5 min to remove cell debris and nuclei, followed by centrifugation at 16 000 Â g, 41C for 1 h to obtain mitochondria. Ultracentrifugation of the post-mitochondrial sample at 100 000 Â g for 1 h at 41C yielded the cytosol. Protein concentrations were determined with bichinonic acid assay. Equal amounts of protein from each fraction were separated by SDS-PAGE and then transferred onto polyvinylidene difluoride membranes. The membranes were incubated with the following antibodies: rabbit polyclonal antibody to inactive and active caspase-3 (1 : 1000), mouse monoclonal anti-cytochrome c (1 mg/ml, 7H8.2C12), rabbit polyclonal anti-Bax-NT and anti-Bak-NT (0.2 mg/ml), mouse monoclonal antibody to caspase-8 (2 mg/ml), polyclonal rabbit anti-SFV capsid (1 : 2000), rat monoclonal anti-Bid (1 mg/ml), or mouse monoclonal anti-actin (1 : 40 000, clone C4) and mouse monoclonal anti-ATP synthase (1 : 2000, clone 7H10) as loading controls. The secondary antibodies were horseradish peroxidase-conjugated anti-mouse, antirabbit (0.16 mg/ml) or anti-rat (1.4 mg/ml) antibodies.
Measurement of DEVDase (caspase-3/-7) activities. Caspase-3/-7 activities were assayed in the cytosol of infected cells by using the tetrapeptides Ac-Asp-Glu-Val-Asp conjugated to 7-amino-4-methylcoumarin (60 mM, Alexis Biochemicals), as described by Egger et al. 40 Gel filtration analysis of the apoptosome. Gel filtration was performed using an AEKTA explorer (Amersham Pharmacia) on a Superose 6 (10/30) column equilibrated with homogenization buffer (see above). The column was calibrated with gel filtration standard proteins of the following molecular masses: blue dextran (2000 kDa), thyroglobulin (669 kDa), ferritin (440 kDa), catalase (232 kDa), aldolase (158 kDa) and bovine serum albumin (66 kDa). A 400 mg potion of cytosolic protein from mock-or SFV-infected (14 h) MEFs was loaded in a 200 ml injection loop (2 mg/ ml protein), and the samples were run at 0.4 ml/min. The eluate was monitored at 280 nm. Fractions of 250 ml were collected and pooled to 1 ml. The 1 ml samples were subjected to a standard trichloroacetic acid precipitation and resuspended in sample buffer containing 3% SDS. A 100 ml portion of the sample was analyzed by anti-Apaf-1 immunoblotting.
